1. Weekly Recap
The major indices delivered a mixed performance in the week ending June 26, with the tech-heavy Nasdaq Composite suffering a sharp 3.3% decline while the Dow Jones Industrial Average eked out a 0.3% gain and the Russell 2000 rose 0.2%. The S&P 500 slipped 1.6%, closing the week at 7,354.02, just below its 50-day moving average of 7,363.43. The dominant theme was a pronounced rotation out of mega-cap technology and into defensive and value-oriented sectors, as investors grappled with rising bond yields and lingering inflation concerns.
What worked this week were healthcare, consumer cyclical, and industrial stocks, with the Healthcare sector gaining 1.13% on average and Consumer Cyclical surging 2.36%. What broke were the high-flying AI and semiconductor names, as NVDA dropped 7.7%, AVGO fell 6.9%, and ORCL cratered 15.2% on no specific company news but amid broader profit-taking and a "capex boom threatens to crowd out buybacks" narrative. The macro backdrop saw the 10-year Treasury yield fall to 4.38% from 4.51% the prior week, a notable decline that provided some support to rate-sensitive sectors. Gold continued its slide, losing 2.8% on the week and now down 6.2% year-to-date, while the US Dollar Index edged up 0.3%.
The volatility regime remained elevated but not panicked, with the VIX rising 6.5% to 18.41, still above its 50-day moving average of 17.79 but below its 200-day of 18.76. The week started with tech weakness and ended with a modest bounce in defensive names, leaving the overall market narrative one of cautious repositioning rather than outright fear.
2. Indices, Vol & Yields
| Index/Asset | Price | Weekly % | YTD % |
|---|---|---|---|
| S&P 500 | 7,354.02 | -1.6% | 7.2% |
| Nasdaq Composite | 25,297.62 | -3.3% | 8.9% |
| Dow Jones Industrial | 51,876.11 | 0.3% | 7.2% |
| Russell 2000 | 3,010.08 | 0.2% | 20.0% |
| CBOE Volatility Index (VIX) | 18.41 | 6.5% | 26.9% |
| Gold (SPDR GLD) | 373.63 | -2.8% | -6.2% |
| US Dollar Index (DXY) | 101.37 | 0.3% | 3.0% |
| Treasury Yield | Yield | Weekly Change |
|---|---|---|
| 2-Year | 4.07% | -0.17% |
| 10-Year | 4.38% | -0.13% |
| 30-Year | 4.87% | -0.08% |
3. Sector Rotation
| Sector | Weekly % | Read |
|---|---|---|
| Consumer Cyclical | 2.36% | Strong risk-on rotation into discretionary spending |
| Healthcare | 1.13% | Defensive bid with GLP-1 tailwinds |
| Industrials | 0.99% | Infrastructure and capex optimism |
| Real Estate | 0.87% | Falling yields support REITs |
| Financial Services | 0.53% | Steady, helped by lower rates |
| Technology | 0.04% | Flat, dragged by mega-cap selloff |
| Utilities | -0.13% | Slight pullback after recent gains |
| Basic Materials | -0.17% | Commodity weakness weighs |
| Consumer Defensive | -0.19% | Staples lag as cyclicals lead |
| Communication Services | -0.43% | Social media regulation fears |
| Energy | -0.53% | Oil price pressure continues |
The rotation this week was a fascinating blend of risk-on and defensive positioning. Consumer Cyclical led the charge, suggesting optimism about the consumer despite Amazon Prime Day headlines about "pinched wallets." Healthcare's strength reflects both defensive demand and the GLP-1 weight-loss drug catalyst (Medicare access news). Technology's near-flat performance masks the deep divergence between mega-cap losers and select winners. The underperformance of Energy and Basic Materials suggests commodity demand concerns persist.
4. Top Movers of the Week
Winners (Top 5 by Weekly %)
| Ticker | Weekly % | YTD % |
|---|---|---|
| MRK | 11.4% | 20.9% |
| JNJ | 10.1% | 22.8% |
| ABBV | 10.1% | 10.5% |
| LLY | 9.6% | 11.8% |
| HD | 6.8% | 0.9% |
Healthcare dominated the winners' list. MRK, JNJ, ABBV, and LLY all surged, likely tied to the Medicare GLP-1 coverage news and broader sector rotation into defensive growth. HD's 6.8% gain reflects housing and consumer cyclical strength.
Losers (Bottom 5 by Weekly %)
| Ticker | Weekly % | YTD % |
|---|---|---|
| ORCL | -15.2% | -24.1% |
| NVDA | -7.7% | 1.9% |
| AVGO | -6.9% | 5.0% |
| TSLA | -6.3% | -13.3% |
| NKE | -5.6% | -35.6% |
ORCL was the week's biggest loser, falling 15.2% with no direct company catalyst, likely caught in the tech rotation and profit-taking after a strong run. NVDA and AVGO, the AI darlings, both suffered as the "capex boom threatens to crowd out buybacks" narrative and analyst caution on AI valuations weighed. NKE continues its brutal year, down 35.6% YTD, as consumer spending shifts and competition intensifies.
5. Earnings Recap
| Ticker | Beat/Miss | EPS Actual vs Est | Key Takeaway |
|---|---|---|---|
| CCL | Beat | $0.41 vs $0.34 | Cruise demand remains strong; revenue slightly missed but EPS beat |
| FDX | Beat | $6.31 vs $5.91 | Strong cost controls and volume growth drove big beat |
No major earnings with reported actuals in the window beyond these two. Both CCL and FDX delivered solid beats, reinforcing the theme of resilient consumer spending and operational efficiency.
6. Macro & News Themes
- AI capex boom vs buybacks: A key narrative emerged that the massive capital spending on AI infrastructure is starting to crowd out share buybacks, a major driver of equity demand. This weighed on tech mega-caps.
- Memory chip AI windfall: WSJ reported that memory chip makers are reaping an AI windfall as prices surge, providing a tailwind for the semiconductor space despite the week's selloff.
- Australia doubles down on social media regulation: Australia is doubling potential penalties for tech firms failing to enforce child social media bans, adding regulatory overhang for Communication Services.
- Amazon Prime Day reveals consumer strain: Headlines noted shoppers are navigating with "pinched wallets," suggesting consumer resilience may be tested.
- Medicare GLP-1 coverage coming: Older Americans will soon have Medicare access to GLP-1 drugs for weight loss, a massive catalyst for healthcare names like LLY and MRK.
- Hong Kong IPO boom: Hong Kong share sales hit a five-year high as the AI boom fuels fundraising, signaling global capital market activity.
- Germany considers raising retirement age to 70: A global theme of aging populations and fiscal pressure, with potential implications for U.S. policy discussions.
7. Stock of the Week
Merck & Co. (MRK) — Up 11.4% on the week, MRK was the standout winner among large caps. The pharmaceutical giant surged as the healthcare sector broadly rallied, driven by the landmark news that Medicare will soon cover GLP-1 drugs for weight loss. While MRK is not a direct GLP-1 player like LLY, the entire sector benefited from the expanded addressable market and renewed investor interest in pharma's growth prospects. Additionally, MRK's strong pipeline and defensive characteristics made it a safe haven during the tech selloff.
For retail investors, MRK's move is significant but comes after a strong YTD run of 20.9%. The stock is now trading well above its 50-day moving average of $115.84 and 200-day of $106.33, suggesting momentum is intact. However, the GLP-1 catalyst is already priced in to some degree, and the stock's valuation is no longer cheap. Risks include patent cliffs on key drugs and potential pricing pressure. For a retail investor, MRK remains a solid core holding for a diversified portfolio, but chasing the week's 11% gain may be risky without a pullback entry.
8. Week Ahead — Catalysts
Upcoming Earnings
| Date | Ticker | EPS Est | Why It Matters |
|---|---|---|---|
| 2026-06-30 | NKE | $0.13 | Consumer spending bellwether; already down 35.6% YTD |
Economic Data: Data unavailable (not in current feeds).
Other Catalysts:
- Continued focus on AI capex vs buyback narrative
- Medicare GLP-1 coverage implementation details
- Any escalation in social media regulation (Australia, potentially U.S.)
9. Levels to Watch
- S&P 500 (7,354.02): Just below its 50-day MA of 7,363.43 — a reclaim would be bullish; failure could test the 200-day at 6,924.97.
- Nasdaq (25,297.62): Below its 50-day MA of 25,778.76 — the tech selloff is technical; next support is the 200-day at 23,625.15.
- Dow (51,876.11): Well above its 50-day MA of 50,293.85 and 200-day of 48,310.78 — the most resilient index.
- Russell 2000 (3,010.08): Above both its 50-day (2,863.98) and 200-day (2,612.96) — small caps remain in a strong uptrend.
- VIX (18.41): Above its 50-day MA of 17.79 but below its 200-day of 18.76 — a close above 18.76 would signal rising fear.
- Gold (373.63): Well below its 50-day MA of 411.81 and 200-day of 409.19 — the trend is decisively bearish.
- US Dollar Index (101.37): Above its 50-day MA of 99.40 and 200-day of 98.89 — dollar strength continues.
10. Sources
- 5 big analyst AI moves: Micron price targets hiked, cautious on SpaceX valuation
- Memory chip makers reap AI windfall as prices surge, WSJ reports
- Australia toughens kids’ social media ban, doubles potential penalties for tech firms
- Capex boom threatens to crowd out buybacks, key equity demand driver
- Hong Kong share sales hit five-year high as AI boom fuels fundraising
- Amazon Prime Day offers a glimpse into U.S. consumer as shoppers navigate with pinched wallets
- Older Americans will soon have Medicare access to GLP-1s for weight loss for the first time
Data Sources: Yahoo Finance, Financial Modeling Prep, U.S. Treasury
Disclaimer: For educational purposes only. Not investment advice. Do your own research.